Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation

Citation
A. Undas et al., Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation, CIRCULATION, 103(18), 2001, pp. 2248-2253
Citations number
28
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CIRCULATION
ISSN journal
00097322 → ACNP
Volume
103
Issue
18
Year of publication
2001
Pages
2248 - 2253
Database
ISI
SICI code
0009-7322(20010508)103:18<2248:SDBCBI>2.0.ZU;2-Z
Abstract
Background-The mechanism of the antithrombotic action of statins is unclear . The aim of this study was to evaluate the effects of simvastatin on the c oagulation process at sites of microvascular injury. Methods and Results-Tissue factor-initiated coagulation was assessed in blo od samples collected every 30 seconds from bleeding-time wounds of 17 patie nts who had advanced coronary artery disease and total cholesterol levels o f 224.6+/-11.8 mg/dL (mean+/-SEM). Quantitative Western blotting for time c ourses of fibrinogen depletion and activation of prothrombin, factor V, and factor XIII was performed before and after 3 months of simvastatin treatme nt (20 mg/d). Simvastatin induced reductions in total cholesterol (23%) and LDL-cholesterol (36%), which were accompanied by significant decreases in the rates of prothrombin activation (16.2+/-2.1%; P=0.004), formation of al pha -thrombin B-chain (27.4+/-1.8%: P=0.001), generation of factor Va heavy chain (29.7+/-3.1%; P=0.007) and factor Va light chain (18.9+/-1.2%; P=0.0 2), factor XIII activation (19.8+/-1.3%; P=0.001), and fibrinogen conversio n to fibrin (72.2+/-3%; P=0.002). Posttreatment fibrinopeptides A and B con centrations, determined by using high-performance liquid chromatography, we re reduced within the last 30 seconds of bleeding. The 30-kDa fragment of t he factor Va heavy chain (residues 307 to 506), produced by activated prote in C, and the 97-kDa fragment of the factor Va heavy chain (residues 1 to 6 43) were released more rapidly after simvastatin treatment. The antithrombo tic actions of simvastatin showed no relationship to its cholesterol-loweri ng action. Conclusions-Simvastatin treatment depresses blood clotting, which leads to reduced rates of prothrombin activation, factor Va generation, fibrinogen c leavage, factor XIII activation, and an increased rate of factor Va inactiv ation. These effects are not related to cholesterol reduction.